Zeria Pharmaceutical

A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia

Role: lead

A Comparative Study of ZG-801 and Placebo in Patients With Hyperkalemia

Role: lead

Trial to Optimally Show the Pharmacological Action of Z-100

Role: lead

Randomized Study of Z-100 Plus Radiation Therapy to Treat Cervical Cancer

Role: lead

Exploratory Study of ZG-801 for the Treatment of Hyperkalemia

Role: lead

Efficacy Study of Intravenous Iron Preparation to Iron Deficiency Anemia

Role: lead

Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia

Role: lead

To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis

Role: lead

Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma

Role: lead

Phase III, Long-term, Open-label Safety Study of Z-338

Role: lead

Mass Balance and Metabolism Study of 14C-Z-215

Role: lead

To Evaluate Pharmacokinetics and Pharmacodynamics of Z-215 in Healthy Male Subjects

Role: lead

To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia

Role: lead

Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia

Role: lead

Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets

Role: lead

A Healthy Subject Study With Z-360 and Placebo

Role: lead

Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis

Role: collaborator

Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase

Role: collaborator

Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC)

Role: lead

To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia

Role: lead